e are grateful to the authors of the 2 editorials on clinical resting-state functional MRI (rs-fMRI) for their positive and constructive comments about the paper published by our group in this issue of the Journal of Neurosurgery. These editorials give us the chance to further highlight limitations and perspectives of the approach we proposed.
matching procedure to label the rs-fMRI networks uses the goodness-of-fit (GOF) metric proposed in Van Dijk et al. 15 In that original study, the GOF metric was applied to rs-fMRI data acquired using MRI systems with different static magnetic field strengths (1.5 T and 3 T) and manufacturers (Siemens and General Electric) to select the best-fitting component to sensorimotor, language, and visual templates. The rs-fMRI data reported in our paper are limited to the use of a 1.5-T MRI GE scanner and to maps derived from a small group of patients with different lesions. We fully agree with the comments in the editorial; the accumulation of a greater number of patients and a wider variety of tumors, MRI systems, and MRI acquisition protocols will be crucial to expand the findings of our first work. We hope that the free distribution of our ReStNeuMap analysis tool will help toward this aim, which was beyond the scope of this first study.
Moreover, since the first draft of this paper, we were very cautious to propose rs-fMRI as a method for intraoperative guidance during resections of brain lesions in eloquent areas. Our main goal was to develop, validate, and make available an automatic, updated, and updatable rs-fMRI analysis tool. This tool is meant to provide neurosurgeons with information about the functional processing of their patients at the whole-brain level and noninvasively, in line with the technical advancements available from the neuroscientific world. Precisely in this light, as extensively discussed in the paper, we decided to compare the functional MRI data obtained with ReStNeuMap with that obtained from direct electrical stimulation (DES), which is considered the most reliable tool (in terms of specificity and sensitivity) for the exploration of human brain function in neurosurgical practice, and it is a mandatory technique for safe resection of lesions in eloquent areas. 2, 6, 7, 13 As we reported, we found good consistency between the functional mapping findings from rs-fMRI and DES, with probabilistic values in the same range as reported in previous and larger comparisons. 3 Therefore, our results contribute to the body of work that supports the validity of the information provided by rs-fMRI data. However, the intrinsic limitations of rs-fMRI do not make it yet a suitable replacement of other methods of functional mapping in awake surgery, such as DES.
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Regarding the limitations of our work, we also appreciate a comment made by Dr. Orringer in his letter (i.e., the lack of comparison between resting-state and task-based fMRI). We acknowledged, in fact, this weakness in our paper. Nevertheless, multiple studies have demonstrated that the sensorimotor, visual, and language rs-fMRI networks have topographies that are similar to those corresponding task-based fMRI activation maps. 1, 14 In addition, the spatial correspondence of functional maps provided by the 2 techniques is never complete because they measure different features of brain function. 5, 8 Task-based fMRI is related to the performance of a task or administration of a stimulus, and the resulting maps represent the brain areas that are directly or indirectly involved in the task. In contrast, rs-fMRI refers to the brain's intrinsic activity, the degree of functional correlation between cortical and subcortical activity, and the resulting maps represent networks of synchronous BOLD activity. 4 However, it has been shown that the degree of correspondence between the localization of preoperative functional activations, of both rs-fMRI and task-based fMRI, with intraoperative recording of functional responses by DES did not show significant differences between these 2 neuroimaging techniques. 12 Therefore, given the possibility of an easy and wider use of rs-fMRI in clinical settings, we are focusing on developing, validating, and distributing a robust rs-fMRI analysis tool.
Finally, we would like to add a few comments, hopefully opening some new perspectives. The neurosurgical community is now in the unique position to have once again in its hands the chance to test, adopt, and possibly improve one of the significant technical advancements in the last 20 years of neuroscientific research. From this perspective, our efforts become a must. The functional information of the brain derived by rs-fMRI has some unique values that could be useful in our departments. Resting-state fMRI data should be, from our perspective, complementary and not alternative to other and well-established tools already included in our practice. Furthermore, rs-fMRI data may be useful not exclusively to complement preoperative planning but also to assess the effects of our treatments, and even more to observe the functional reorganization over the follow-up, especially in some fields of our practice, such as neuro-oncology, vascular surgery and brain trauma, and others (e.g., neurology, intensive care, radiotherapy, oncology, etc.).
To conclude, our work had 2 main goals. The first was to provide a user-friendly, testable, and updatable rs-fMRI analysis tool that may help us to comprehend, at the individual level, the functional assessment of patients in treatment planning as well as in evaluating the effects of those and the posttreatment plasticity. Second, as interestingly highlighted by Roland and Smyth in their editorial, we are hopefully contributing to strengthen the bridge between the neurosurgery and neuroscience worlds, to mutually improve knowledge and experiences of these 2 inseparable fields. We hope that such multidisciplinary efforts will contribute to taking us beyond the challenges of treating and evaluating brain diseases.
